Hi, help us enhance your experience
Hi, help us enhance your experience
Hi, help us enhance your experience
4209 Views
eMediNexus 12 February 2018
which is under consideration and is pending approval. HCFI can give its suggestions on the draft policy as one of the policy initiative is one drug one company one and encouraging medical practitioners to prescribe generic name drugs instead of brand names.
The key objectives of the Policy is to:
{{Article_Title}}
{{Article_Author}}
{{Article_Title}}
{{Article_Author}}
{{Article_Title}}..
Age of Onset of Type 2 Diabetes: Predictor of Renal Outcomes..
Resistance Exercise vs Aerobic Exercise: Uncovering the Superior Strat.....
Benefits of Testosterone Replacement Therapy in Cirrhosis..
Impact of Past Moraxella Catarrhalis Infection in COPD Outcomes..
Small Dense LDL-C: A Marker for Lower Extremity Arterial Disease in Ty.....
{{Article_Title}}..
DGHS Directs Physiotherapists Not to Use ‘Dr.’ Prefix..
India Faces Rising Childhood Obesity amid Shifts in Diet and Lifestyle..
Supreme Court Grants States Four Weeks to File Affidavits on PCPNDT Implementation..
SC: Failed Treatment Doesn’t Imply Negligence; Overturns ₹20 Lakh Compensation Order..
Nearly Half of Global Diabetes Cases Remain Undiagnosed, Lancet Study Warns..